GSK Aims to Market First Malaria Vaccine - Presented by: The Aol. On Network

Malaria kills hundreds of thousands of people every year, mostly babies in sub-Saharan Africa. This child in Tanzania is taking part in a trial for the world's first malaria vaccine RTS,S Britain's GlaxoSmithKline is hoping to get marketing approval for the injection next year after the trial significantly cut cases in children. Scientists say an effective vaccine is key for eradicating malaria. Doctor Allan Pamba helped carry out the trial for GSK.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 117.60 1.03 ▼ 0.86%
PBR $ 10.39 0.11 ▼ 1.05%
BAC $ 17.10 0.08 ▼ 0.47%
PBR/A $ 11.02 0.04 ▼ 0.36%
KMI $ 40.75 0.04 ▼ 0.10%
F $ 15.68 0.01 ▲ 0.06%
FB $ 75.63 1.62 ▲ 2.19%
HBAN $ 10.11 0.07 ▼ 0.69%

As of 11/25/2014, 04:15 PM
More Most Active